Quick Summary
Ranizurel 0.3mg Injection
Last updated on 26 Sep 2026 | 08:41 AM (IST)
₹5678
MRP: ₹11240.63
(You Save ₹5562.63)
1 VIAL(s)
Ranizurel 0.3mg Injection
Salt Composition
RANIBIZUMABMarketer
RELIANCE LIFE SCIENCES PVT LTD
Prepaid Only. Non-Returnable.
49% OFF
₹5678
MRP: ₹11,240.63
Inclusive of all taxes
49% Off
Salt Composition
RANIBIZUMABMarketer
RELIANCE LIFE SCIENCES PVT LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Better Service Satisfied Customers
Introduction
Ranizurel 0.3mg Injection, contains the active ingredient Ranibizumab. It is an anti-neovascularisation agent in the class of medications called vascular endothelial growth factor A (VEGF-A) antagonists. It is used in adults to treat several eye diseases causing vision impairment. It is used to treat wet age-related macular degeneration (AMD, a persistent eye disease that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities).
Ranizurel 0.3mg Injection is also used to treat myopic choroidal neovascularization (mCNV; a complication in near-sighted people where new blood vessels can grow in the back of the eye), and to treat macular edema after retinal vein occlusion (an eye disease caused by blockage of blood flow from the eye that leads to blurry vision and vision loss). It is also used to treat diabetic macular edema (an eye disease caused by diabetes that can lead to vision loss) and diabetic retinopathy (damage to the eyes caused by diabetes).
Do not use Ranizurel 0.3mg Injection if you are allergic to Ranibizumab or other ingredients of this medicine. Do not take this medicine if you have an infection in or around your eye and if you have pain or redness in your eye. Inform your doctor immediately if you develop symptoms such as eye pain or increased discomfort, worsening eye redness, blurred or decreased vision, an increased number of small particles in your vision, or increased sensitivity to light. Inform your doctor if you have a prior history of eye conditions or eye treatments or had a stroke before initiating the treatment.
Uses of Ranizurel 0.3mg Injection
Ranizurel 0.3mg Injection is used to treat several eye diseases causing vision impairment, including,
-
Age-related macular degeneration
-
Macular edema
-
Diabetic macular edema and retinopathy
-
Myopic choroidal neovascularization
-
Retinal vein occlusion
How Ranizurel 0.3mg Injection works
Ranizurel 0.3mg Injection specifically recognizes and binds to a protein called human vascular endothelial growth factor A (VEGF-A) present in the eye. In excess, VEGF-A causes abnormal blood vessel growth and swelling in the eye, leading to impairment of vision in certain eye diseases. This medicine can block its actions and prevent this abnormal growth and swelling. This injection can help to stabilize and improve your vision.
Interaction of Ranizurel 0.3mg Injection with other drugs
Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications interact with Ranizurel 0.3mg Injection and reduce their effectiveness by causing undesirable side effects.
Storage Conditions
-
Store in a refrigerator (2°C – 8°C)
-
Do not freeze
-
Protect the medicine from light and excessive moisture.
-
Keep the medicine out of reach of children and pets.
How to consume Ranizurel 0.3mg Injection
Ranizurel 0.3mg Injection is administered as an injection into your eye by an eye doctor under a local anesthetic. Your doctor will decide the dose and frequency of the injection based on your disease condition. Do not self-administer the medicine.
Safety Advices
Breast Feeding
Ranizurel 0.3mg Injection should not be used in breastfeeding women because the medicine passes into the breast milk in small amounts and may harm your baby. Inform your physician if you are breastfeeding.
Alcohol
It is unknown whether it is safe to consume alcohol while taking Ranizurel 0.3mg Injection. Inform your physician if you are an alcoholic.
Liver
It is unknown whether Ranizurel 0.3mg Injection can be used in patients with liver disorders. Inform your physician if you have any liver disease before initiating the therapy.
Lungs
It is unknown whether Ranizurel 0.3mg Injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Driving
It is unsafe to drive after taking Ranizurel 0.3mg Injection because it may cause temporary vision blurring. Do not drive or operate heavy machinery until the symptoms resolve.
Pregnancy
Ranizurel 0.3mg Injection should not be used during pregnancy because it may cause risk to the unborn child. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant during the treatment. Use effective contraception during treatment and at least three months after the last dose.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Common
-
Pain and swelling in the eye
-
Bleeding in the eye
-
Blurred vision
-
Urinary tract infection
-
Skin rashes
-
Discharge from the eye
Serious
-
Tear of the layer in the back of the eye
-
Flashes of light in the eye
-
Temporary loss of sight
-
Clouding of lens
-
Infection of the eyeball
Expert Tips
-
Not recommended for children or teens – Ranizurel 0.3mg Injection should not be used in individuals below 18 years of age due to a lack of safety data.
-
Elderly patients may need dose adjustments – People over 65 can use this injection but may require modified doses based on their health condition.
-
Seek immediate help for eye symptoms – If your eye becomes red, painful, sensitive to light, or if your vision changes, consult an eye doctor right away.
-
Follow-up is important – Your doctor will monitor your eye and decide if further injections are needed based on how well you're responding.
-
Stick to your doctor’s advice – Do not skip or delay your injections. Follow all medical instructions carefully for the best outcome.
FAQs
Q1.
What is the duration of treatment for Ranizurel 0.3mg Injection?
The duration of the treatment with Ranizurel 0.3mg Injection depends on your disease condition. Your doctor will decide the dose and frequency of the treatment based on your response.
Q2.
What are the contraindications for Ranizurel 0.3mg Injection?
Do not use Ranizurel 0.3mg Injection if you are allergic to ranibizumab or other ingredients of this medicine. Do not take this medicine if you have an infection in or around your eye and if you have pain or redness in your eye. This medicine should not be used during pregnancy and breastfeeding.
Q3.
Does Ranizurel 0.3mg Injection increase the risk of stroke?
Ranizurel 0.3mg Injection can increase your chances of high blood pressure and stroke. Inform your physician if you have a history of stroke before initiating the treatment.
Q4.
What is Ranizurel 0.3mg Injection indication?
Ranizurel 0.3mg Injection is used in adults to treat certain eye diseases that cause visual impairment.
Q5.
What are the serious side effects of Ranizurel 0.3mg Injection?
The serious side effects of Ranizurel 0.3mg Injection are a tear of the layer in the back of the eye, flashes of light in the eye, temporary loss of sight, clouding of the lens, and eyeball infection.
Fact Box
|
Molecule Name: Ranibizumab |
Therapeutic Class: Anti-neovascularisation agents |
|
Pharmacological Class: Vascular endothelial growth factor A (VEGF-A) |
Indications: Treat certain eye diseases that cause visual impairment. |
References
-
Lucentis 10 mg/ml solution for injection - Patient Information Leaflet (PIL) - (emc). www.medicines.org.uk. [Revised Nov 2022] [cited 2023 Jun 9]. Available from: https://www.medicines.org.uk/emc/product/307/pil
-
Genentech, Inc, Lucentis [ranibizumab injection]. Access.fda.gov. [revised October 2014] [cited 2023 Jun 9]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125156s105lbl.pdf
-
James E Frampton; Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration; Drugs & Aging; Published on May 2013; Accessed on June 09 2023; https://pubmed.ncbi.nlm.nih.gov/23539234/
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
P. Thirumal Reddy
B. Pharm

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 26 Sep 2026 | 08:41 AM (IST)

Want to know more?
Read Our Editorial Policy







